KevinYLi123 (Talk | contribs) |
Laurenhong11 (Talk | contribs) |
||
Line 450: | Line 450: | ||
</div> | </div> | ||
<table> | <table> | ||
− | The Lambert iGEM team was able to collaborate with the Emory iGEM team to discuss the ethics about | + | The Lambert iGEM team was able to collaborate with the Emory iGEM team to discuss the ethics about CRISPR Cas9 along with a group of other Emory students and professors. Through this discussion, they were able to gain knowledge about the different perspectives of genetic modification and to what extent people are willing to justify experiments as ethical. Also, the Emory iGEM team led a tour of their labs to demonstrate their daily lab workings, allowing both teams to grasp the overall purpose of each other’s projects. Lambert used this ethics conference as a springboard for their own investigations into ethics. As a result the team developed a simple flowchart for the synthetic biologists to use when considering the ethics of their own projects. Members of the team also attended a Business Ethics Experience held by the University of North Georgia. |
</table> | </table> | ||
<br><br><br><br> | <br><br><br><br> |
Revision as of 03:35, 2 November 2017
Collaborations
For more information, see our Silver Human Practices page.